naringenin has been researched along with Psoriasis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alalaiwe, A; Chen, EL; Fang, JY; Hsiao, CY; Lien, WC; Lin, CF; Lin, CY | 1 |
Chlapanidas, T; Collina, S; Faragò, S; Gaggeri, R; Leoni, F; Marazzi, M; Martino, E; Perteghella, S; Rossi, D | 1 |
2 other study(ies) available for naringenin and Psoriasis
Article | Year |
---|---|
Development of flavanone and its derivatives as topical agents against psoriasis: The prediction of therapeutic efficiency through skin permeation evaluation and cell-based assay.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Female; Flavanones; Humans; Imiquimod; Keratinocytes; Mice; Models, Biological; Models, Molecular; Permeability; Psoriasis; Skin; Skin Absorption; Specific Pathogen-Free Organisms; Structure-Activity Relationship; Swine; Water Loss, Insensible | 2020 |
TNF-α blocker effect of naringenin-loaded sericin microparticles that are potentially useful in the treatment of psoriasis.
Topics: Cells, Cultured; Chemistry, Pharmaceutical; Cytokines; Down-Regulation; Flavanones; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Microspheres; Particle Size; Psoriasis; Sericins; Tumor Necrosis Factor-alpha | 2014 |